Medscape Hematology-Oncology is pleased to present the latest update to the NCCN Clinical Practice Guidelines in Oncology™ Prostate Cancer, released in December 2009. The updated NCCN Guideline, ...

National Comprehensive Cancer Network publishes new guidelines for Pediatric Soft Tissue Sarcomas, focused on rhabdomyosarcoma. PLYMOUTH MEETING, Pa., Feb. 17, 2026 /PRNewswire/ -- The National ...

Distress management guideline updates aim to destigmatize the psychosocial effects of cancer and treatment, and encourage patients with cancer to seek help.

The NCCN has updated its guidelines on breast, pancreatic, colon, rectal, non-small cell lung, and other cancers. The National Comprehensive Cancer Network (NCCN) has updated its treatment guidelines ...

Boehringer Ingelheim announced that Hernexeos (zongertinib tablets) has been recommended as an initial treatment option for adult patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer ...

PLYMOUTH MEETING, PA [October 6, 2025] — Today, the National Comprehensive Cancer Network ® (NCCN ®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN ...

New guidelines provide a framework for pediatric neuroblastoma treatment — as well as conversations families should have with their oncology teams. Newly crafted guidelines could help guide the ...

The National Comprehensive Cancer Network ® (NCCN ®) - an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care - announces the ...

Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines. Aaron Gerds, MD, MS: The NCCN [National Comprehensive Cancer Network] guidelines ...

FDA approved concept. Rubber stamp with FDA and medicine. 3d illustration Cancer drugs that are granted accelerated approval are less likely than drugs with regular approval to be given high-level ...

Panelists discuss how payer coverage restrictions often conflict with NCCN guidelines for BTK inhibitor therapies in CLL, impeding evidence-based care. Panelists discuss how payer coverage often ...

PLYMOUTH MEETING, Pa., Feb. 10, 2026 /PRNewswire/ -- Getting a cancer diagnosis is a life-changing event. Appointments take over the calendar, and the onslaught of new information can be overwhelming.